Anika Therapeutics grants employee RSUs
Analysis based on 9 articles · First reported Apr 03, 2026 · Last updated Jun 05, 2026
The market impact is minimal as these are routine inducement grants for new employees by Anika Therapeutics, Inc. Such grants are a common practice to attract and retain talent, and the number of shares granted is relatively small, thus not significantly affecting the stock price of Anika Therapeutics, Inc.
Anika Therapeutics, Inc. announced two separate grants of restricted stock units (RSUs) to newly hired non-executive employees. On April 1, 2026, 3,138 shares were granted, and on June 1, 2026, 3,360 shares were granted. These grants were made under the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, and were approved by the compensation committee of the board of directors. The grants comply with Nasdaq-100 Listing Rule 5635(c)(4) and serve as a material inducement for the employees' acceptance of employment. The RSUs will vest in three equal installments over three years, contingent on continuous service to Anika Therapeutics, Inc.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard